Constellation Technologies (ASX:CT1) reported a 5% revenue decline to $1.71 million and a $458,246 net loss for FY26, weighed down by delayed hardware deployments and increased expenses. Recurring subscription revenue grew 22%, reflecting ongoing customer engagement.
- 5% revenue decline to $1.71 million in FY26
- Net loss of $458,246 versus prior year profit
- Recurring platform revenue up 22% to $856,453
- Hardware deployment delays deferred $226k revenue
- No dividends declared; cash reserves at $442k
Revenue Impacted by Deployment Delays
Constellation Technologies Limited (ASX:CT1) reported a 5% drop in revenue for FY26 to $1.71 million, compared to $1.81 million the previous year. The decline primarily reflects delays in hardware delivery and installation at customer sites, which deferred $226,221 of revenue recognition into the first quarter of FY27. While reported revenue dipped, cash receipts from customers actually rose 11% to $2.06 million, suggesting stronger underlying activity than the headline figures imply.
The company’s IoT-enabled food safety and compliance solutions continue to see traction, particularly through its Callisto and Meridian platforms. Recurring platform and subscription revenue grew 22% to $856,453, underscoring progress in building a sustainable, recurring income base amid broader operational challenges.
Loss Driven by Deferred Revenue and Rising Costs
Constellation swung to a net loss of $458,246 in FY26, a stark contrast to a modest $9,521 profit in FY25. The loss was driven by the deferred revenue recognition, increased hardware and software costs, and impairment charges related to the early retirement of a handheld temperature device. The impairment of $72,558 reflects the company’s decision to cease manufacturing that product, though it will continue support in the near term.
Operating expenses remained elevated, with general and administrative costs holding steady at around $1.19 million, and amortisation nearly doubling to $191,070 as the company capitalised and expensed further development costs. The company’s cash reserves declined to $442,082, down from $554,824 the prior year, but remain sufficient to support ongoing operations.
Product Development and Market Expansion Efforts
Management highlighted significant advancements in the Callisto platform, which now integrates resident meal-ordering capabilities tailored for aged care, linking dietary requirements directly with food safety processes. The platform also expanded its footprint in healthcare, central production kitchens, and complex food service environments, with an emphasis on traceability and operational compliance.
Hardware innovation continued with the development of the Callisto Smart Probe, combining temperature measurement and digital workflows to streamline frontline operations. Efforts to enhance supply chain reliability and deployment planning were flagged as priorities to mitigate the delays experienced in FY26.
Governance and Remuneration Highlights
The board, chaired by Raymond Malone, maintained a disciplined investment approach despite the financial setbacks. No dividends were declared for FY26, consistent with prior years. Key management personnel remuneration remained stable, with CEO Kartheek Munigoti receiving $271,907 in total compensation, including share-based payments linked to performance incentives. The company’s employee share option plan continues to be a key retention tool, with 38.5 million options and 16 million performance rights outstanding, although recent tranches of performance rights failed to vest due to unmet conditions.
Constellation’s governance framework remains robust, with ongoing oversight of risks including customer demand volatility, technology obsolescence, and key personnel retention. The company continues to operate on a going concern basis, supported by its cash position, R&D tax incentives, and potential access to capital markets if required.
Bottom Line?
Execution on hardware deployments and converting customer activity into revenue growth will be pivotal for Constellation’s FY27 performance.
Questions in the middle?
- Will Constellation successfully overcome supply chain and deployment bottlenecks to accelerate revenue recognition in FY27?
- How effectively can the company scale its recurring platform revenue amid a competitive IoT food safety market?
- What impact will the cancellation of recent performance rights have on executive incentives and retention?